发明授权
US08101185B2 Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
有权
抗-Il-5抗体组合物由于糖基化而显示出细胞毒性
- 专利标题： Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
- 专利标题（中）： 抗-Il-5抗体组合物由于糖基化而显示出细胞毒性
-
申请号： US12818363申请日： 2010-06-18
-
公开(公告)号： US08101185B2公开(公告)日： 2012-01-24
- 发明人: Yutaka Kanda , Mitsuo Satoh , Kazuyasu Nakamura , Kazuhisa Uchida , Toyohide Shinkawa , Naoko Yamane , Motoo Yamasaki , Nobuo Hanai , Emi Hosaka , Kazuya Yamano
- 申请人： Yutaka Kanda , Mitsuo Satoh , Kazuyasu Nakamura , Kazuhisa Uchida , Toyohide Shinkawa , Naoko Yamane , Motoo Yamasaki , Nobuo Hanai , Emi Hosaka , Kazuya Yamano
- 申请人地址： JP Tokyo
- 专利权人： Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人： Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Sughrue Mion, PLLC
- 优先权： JPP.2000-308526 20001006; WOPCT/JP01/08804 20011005
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K39/00 ; C07K16/00 ; C12P21/08
摘要：
The present invention relates to a cell for the production of an anti-IL-5 antibody molecule having high antibody-dependent cell-mediated cytotoxic activity, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.
公开/授权文献
信息查询
